Published in Biotech Law Weekly, July 2nd, 2004
Specifically, a "humanized" mouse is claimed by AMDL that has been engineered to possess a human-like immune system. This transgenic mouse is extremely useful for studying potential therapeutic benefits of candidate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.